ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression

BACKGROUND: Resistance to platinum-based chemotherapy is a major cause of therapeutic failure during the treatment of epithelial ovarian cancer (EOC) patients. Our study aims to elucidate the molecular mechanisms by which ZNF711 down regulation promotes CISPLATIN resistance in EOC. METHODS: ZNF711 e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Geyan, Peng, Hu, Tang, Miaoling, Yang, Meisongzhu, Wang, Jun, Hu, Yameng, Li, Ziwen, Li, Jun, Li, Zheng, Song, Libing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441092/
https://www.ncbi.nlm.nih.gov/pubmed/34521054
http://dx.doi.org/10.1016/j.ebiom.2021.103558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441092/
https://www.ncbi.nlm.nih.gov/pubmed/34521054
http://dx.doi.org/10.1016/j.ebiom.2021.103558

Ejemplares similares